Vaccine Market Evolution: Growth Drivers and Strategies of Leading Players

I. D.'s Blog

Posted: Sun March 31 11:36 PM PDT
Member: Isha Deshpande
Updated: Sun March 31 11:38 PM PDT

The global vaccine market size reached USD 45.20 Billion in 2021 and is expected to register a revenue CAGR of 9.7% during the forecast period, according to latest analysis by Emergen Research. Increase in infectious diseases in developing countries is one of the key factors driving market revenue growth. Global rise in prevalence of infectious illnesses increases healthcare burden on countries and has an impact on their socio-economic growth. In addition, rise in prevalence of infectious diseases, such as malaria, influenza, hepatitis, and HIV/AIDS, is driving revenue growth. Moreover, emergence of drug-resistant microbial strains has hampered efforts to combat infectious illnesses such as pneumonia, cholera, malaria, and diarrhea, among others.

The report studies the historical data of the Vaccine market and offers valuable information about the key segments and sub-segments, revenue generation, demand and supply scenario, trends, and other vital aspects. The report offers an accurate forecast estimation of the Vaccine industry based on the recent technological and research advancements. It also offers valuable data to assist the investors in formulating strategic business investment plans and capitalize on the emerging growth prospects in the Vaccine market.

Get Download Pdf Sample Copy of this Report@ https://www.emergenresearch.com/request-sample/290

Competitive Terrain:

The global Vaccine industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.

The leading market contenders listed in the report are:

Pfizer, Inc., CSL Limited, Merck & Co., Inc., AstraZeneca, Johnson & Johnson, Serum Institute of India Pvt., Ltd., GlaxoSmithKline PLC, Sanofi Pasteur SA, Emergent Biosolutions, Inc., and Biological E

Key market aspects studied in the report:

Market Scope: The report explains the scope of various commercial possibilities in the global Vaccine market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.

Competitive Outlook: The leading companies operating in the Vaccine market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.

Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global Vaccine market.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now)@ https://www.emergenresearch.com/request-discount/290

Market Segmentations of the Vaccine Market

This market is segmented based on Types, Applications, and Regions. The growth of each segment provides accurate forecasts related to production and sales by Types and Applications, in terms of volume and value for the period between 2022 and 2030. This analysis can help readers looking to expand their business by targeting emerging and niche markets. Market share data is given on both global and regional levels. Regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Research analysts assess the market positions of the leading competitors and provide competitive analysis for each company. For this study, this report segments the global Vaccine market on the basis of product, application, and region:

Emergen Research has segmented the vaccine market based on type, patient type, disease, technology, and region:

Type Outlook (Revenue, USD Billion; 2019–2030)
- Monovalent Vaccine
- Multivalent Vaccine

Patient Type Outlook (Revenue, USD Billion; 2019–2030)
- Adult
- Pediatric

Disease Outlook (Revenue, USD Billion; 2019–2030)
- Human Papillomavirus (HPV)
- Pneumococcal Diseases
- Hepatitis
- Influenza
- Diphtheria, Tetanus, Pertussis (DTP)
- Polio
- Covid-19
- Herpes Zoster
- Rotavirus
- Varicella
- Meningococcal Disease
- Others

Technology Outlook (Revenue, USD Billion; 2019–2030)
- Conjugate Vaccines
- Inactivated & Subunit Vaccines
- Live Attenuated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Viral Vector Vaccines
- Covid-19 vaccines
  1. Covaxin
  2. Covidshield
  3. Sputnik Light Vaccine
  4. Corbevax Vaccine